Literature DB >> 12882890

A novel serotonin blocker, sarpogrelate, increases circulating adiponectin levels in diabetic patients with arteriosclerosis obliterans.

Jun'ichi Yamakawa, Takashi Takahashi, Tohoru Itoh, Kazuya Kusaka, Ken Kawaura, Xin Qui Wang, Tsugiyasu Kanda.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12882890     DOI: 10.2337/diacare.26.8.2477

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  5 in total

1.  Portal 5-hydroxytryptophan infusion enhances glucose disposal in conscious dogs.

Authors:  Mary Courtney Moore; Kazuhiro Kimura; Haruki Shibata; Tsutomu Honjoh; Masayuki Saito; Carrie A Everett; Marta S Smith; Alan D Cherrington
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-03-08       Impact factor: 4.310

2.  Reduced albuminuria with sarpogrelate is accompanied by a decrease in monocyte chemoattractant protein-1 levels in type 2 diabetes.

Authors:  Susumu Ogawa; Takefumi Mori; Kazuhiro Nako; Tsuneo Ishizuka; Sadayoshi Ito
Journal:  Clin J Am Soc Nephrol       Date:  2008-01-30       Impact factor: 8.237

3.  Blockade of serotonin 2A receptor improves glomerular endothelial function in rats with streptozotocin-induced diabetic nephropathy.

Authors:  Shinya Kobayashi; Minoru Satoh; Tamehachi Namikoshi; Yoshisuke Haruna; Sohachi Fujimoto; Sayaka Arakawa; Norio Komai; Naruya Tomita; Tamaki Sasaki; Naoki Kashihara
Journal:  Clin Exp Nephrol       Date:  2008-01-05       Impact factor: 2.801

Review 4.  Peripheral Serotonin: a New Player in Systemic Energy Homeostasis.

Authors:  Jun Namkung; Hail Kim; Sangkyu Park
Journal:  Mol Cells       Date:  2015-12-01       Impact factor: 5.034

5.  Sarpogrelate hydrochloride ameliorates diabetic nephropathy associated with inhibition of macrophage activity and inflammatory reaction in db/db mice.

Authors:  Eun Soo Lee; Mi Young Lee; Mi-Hye Kwon; Hong Min Kim; Jeong Suk Kang; You Mi Kim; Eun Young Lee; Choon Hee Chung
Journal:  PLoS One       Date:  2017-06-22       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.